Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus
Laura K. McMullan
, Mike Flint
, Julie Dyall
, César Albariño
,
Gene G. Olinger
, Scott Foster
, Phiroze Sethna
, Lisa E. Hensley
, Stuart T. Nichol
, E. Randall Lanier
, Christina F. Spiropoulou
Research output
:
Contribution to journal
›
Article
›
peer-review
48
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lipids
100%
Antiviral Activity
100%
Ebola Virus
100%
Brincidofovir
100%
Double-stranded DNA Virus
40%
Cidofovir
40%
1-Propanol
40%
Mechanism of Action
20%
RNA Virus
20%
Phosphorylation
20%
Lipid-drug Conjugate
20%
In Vitro Activity
20%
Human Cell Lines
20%
Cytomegalovirus
20%
Diphosphate
20%
Broad-spectrum Activity
20%
Multiple Persons
20%
Acyclic nucleoside Phosphonates
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antiviral Activity
100%
Ebola Virus
100%
Brincidofovir
100%
Double-Stranded DNA Virus
40%
Cidofovir
40%
Propanol
40%
Infection
20%
Cytomegalovirus
20%
Pyrophosphate
20%
Phosphonate
20%
Acyclic Nucleoside
20%
RNA Virus
20%